Zelira Therapeutics Limited (OTCMKTS:ZLDAF – Get Free Report) dropped 27.6% during trading on Thursday . The company traded as low as $0.38 and last traded at $0.40. Approximately 5,005 shares traded hands during trading, an increase of 244% from the average daily volume of 1,454 shares. The stock had previously closed at $0.55.
Zelira Therapeutics Trading Up 10.6 %
The stock’s 50 day simple moving average is $0.35 and its 200 day simple moving average is $0.47.
About Zelira Therapeutics
Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of various medical conditions in Australia and the United States. The company offers formulations under the HOPE brand in Australia, Washington, Pennsylvania, and Louisiana, as well as develops Zenivol, a cannabinoid-based medicine for treatment of chronic insomnia.
Further Reading
- Five stocks we like better than Zelira Therapeutics
- There Are Different Types of Stock To Invest In
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
- Top Stocks Investing in 5G Technology
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Intel Loses a Quarter of Its Value After Horrible Earnings Report
Receive News & Ratings for Zelira Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zelira Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
